Chemistry & Biodiversity · 2006 · 76 citations · 31 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyDopaminergic PharmacologyDrug-receptor InteractionsLigand BindingSerotonergic PharmacologyStructure-activity Relationship Analysis5-Hydroxytryptamine Receptor PharmacologyBiological Evaluation ReportD2-like Dopamine ReceptorsDopamine D2-like ReceptorsReceptor Binding ProfilesSelectivitySerotonergic Drug DiscoverySerotonin Receptor Pharmacology
Four new diaza analogues (14, 15, 23, and 24) of the conformationally constrained aminobutyrophenone derivatives QF0104B (5) and QF0108B (6) were synthesized (Schemes 2 and 3), and evaluated for their binding affinities (Table) towards the serotonin 5-HT2A and 5-HT2C, and the dopamine D2 receptors. Among the new compounds, the quinazoline derivative 15 (= 7-{[4-(4-fluorobenzoyl)piperidin-1-yl]methyl}-5,6,7,8-tetrahydroquinazolin-5-one) exhibited the highest affinities towards the serotonin 5-HT2A and dopamine D2 receptors, and it is in the borderline of potential atypical antipsychotics. The cinnoline derivative 23 (= 7-{[4-(4-fluorobenzoyl)piperidin-1-yl]methyl}-5,6,7,8-tetrahydro-3-methylcinnolin-5-one) displayed high selectivity in its binding profile towards the 5-HT2C compared to both the 5-HT2A and D2 receptors.
31
The pharmacological basis of therapeutics
Isaac Starr · American Heart Journal · 1941 · 1.9K citations
Antipsychotic drug doses and neuroleptic/dopamine receptors
Philip Seeman, T. Lee, M. Chau-Wong et al. · Nature · 1976 · 1.6K citations
Medicine, Pharmacology, Psychiatry +13
Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors
Paul R. Sanberg · Nature · 1980 · 310 citations
Medicine, Neuroscience, Pharmacology +14